Insulin Antikörper (AA 35-64)
Kurzübersicht für Insulin Antikörper (AA 35-64) (ABIN3028737)
Target
Alle Insulin (INS) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 35-64
-
Aufreinigung
- Purified
-
Immunogen
- A portion of amino acids 35-64 from the human protein was used as the immunogen for this anti-Insulin antibody.
-
Isotyp
- IgM
-
-
-
-
Applikationshinweise
- Titration of the anti-Insulin antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 1:100-1:500
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS pH 7.4 with 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the anti-Insulin antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
-
-
- Insulin (INS)
-
Andere Bezeichnung
- Insulin
-
Hintergrund
- Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. [UniProt]
-
UniProt
- P01308
-
Pathways
- NF-kappaB Signalweg, RTK Signalweg, Positive Regulation of Peptide Hormone Secretion, Peptide Hormone Metabolism, Hormone Activity, Carbohydrate Homeostasis, ER-Nucleus Signaling, Regulation of Carbohydrate Metabolic Process, Feeding Behaviour, Autophagie, Negative Regulation of intrinsic apoptotic Signaling, Brown Fat Cell Differentiation, Positive Regulation of fat Cell Differentiation
Target
-